Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Stephens 

HCA Holdings Inc. diskutieren

HCA Holdings Inc.

WKN: A1JFMW / Symbol: HCA / Name: HCA Holdings / Aktie / Anbieter & Dienstleistungen / Large Cap /

411,50 €
-0,54 %

HCA Healthcare, Inc. (NYSE: HCA) was upgraded by analysts at Stephens to a "strong-buy" rating.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 25,80 %
Kursziel 351,36
Veränderung
Endet am 23.06.26

HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Royal Bank Of Canada from $376.00 to $404.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,02 %
Kursziel 357,40
Veränderung
Endet am 16.07.26

HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Truist Financial Corporation from $390.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 43,83 %
Kursziel 341,33
Veränderung
Endet am 28.07.26

HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Royal Bank Of Canada from $404.00 to $401.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 43,83 %
Kursziel 331,97
Veränderung
Endet am 28.07.26

HCA Healthcare, Inc. (NYSE: HCA) had its price target lowered by analysts at Barclays PLC from $416.00 to $390.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,97 %
Kursziel 381,40
Veränderung
Endet am 26.08.26

HCA Healthcare (NYSE:HCA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $444.00 price target on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 20,92 %
Kursziel 376,78
Veränderung
Endet am 18.09.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Barclays PLC from $390.00 to $445.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 9,91 %
Kursziel 379,53
Veränderung
Endet am 07.10.26

HCA Healthcare (NYSE:HCA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $444.00 price target on the stock.
Ratings data for HCA provided by MarketBeat

HCA Healthcare (NYSE:HCA) had its "overweight" rating reaffirmed by analysts at KeyCorp.
Ratings data for HCA provided by MarketBeat

HCA Healthcare (NYSE:HCA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for HCA provided by MarketBeat

HCA Healthcare (NYSE:HCA) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,06 %
Kursziel 433,95
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Mizuho from $475.00 to $505.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,06 %
Kursziel 429,65
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $400.00 to $500.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,06 %
Kursziel 408,17
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at KeyCorp from $465.00 to $475.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,06 %
Kursziel 425,35
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Truist Financial Corporation from $460.00 to $495.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat

HCA Healthcare (NYSE:HCA) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for HCA provided by MarketBeat

HCA Healthcare (NYSE:HCA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,65 %
Kursziel 429,65
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Stephens from $450.00 to $500.00. They now have an "overweight" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,65 %
Kursziel 414,18
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Royal Bank Of Canada from $449.00 to $482.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,70 %
Kursziel 421,06
Veränderung
Endet am 27.10.26

HCA Healthcare (NYSE:HCA) had its price target raised by analysts at TD Cowen from $380.00 to $490.00. They now have a "buy" rating on the stock.
Ratings data for HCA provided by MarketBeat